An engineered split M.HhaI-zinc finger fusion lacks the intended methyltransferase specificity

Glenna E. Meister, Srinivasan Chandrasegaran, Marc Ostermeier

Research output: Contribution to journalArticle

Abstract

The ability to site-specifically methylate DNA in vivo would have wide applicability to the study of basic biomedical problems as well as enable studies on the potential of site-specific DNA methylation as a therapeutic strategy for the treatment of diseases. Natural DNA methyltransferases lack the specificity required for these applications. Nomura and Barbas [W. Nomura, C.F. Barbas 3rd, In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase, J. Am. Chem. Soc. 129 (2007) 8676-8677] have reported that an engineered DNA methyltransferase comprised of fragments of M.HhaI methyltransferase and zinc finger proteins has very high specificity for the chosen target site. Our analysis of this engineered enzyme shows that the fusion protein methylates target and non-target sites with similar efficiency.

Original languageEnglish (US)
Pages (from-to)226-230
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume377
Issue number1
DOIs
StatePublished - Dec 5 2008

Fingerprint

Zinc Fingers
Methyltransferases
Zinc
Fusion reactions
DNA Methylation
DNA
DNA sequences
Proteins
Enzymes
Therapeutics

Keywords

  • DNA methylation
  • Protein engineering
  • Zinc fingers

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

An engineered split M.HhaI-zinc finger fusion lacks the intended methyltransferase specificity. / Meister, Glenna E.; Chandrasegaran, Srinivasan; Ostermeier, Marc.

In: Biochemical and Biophysical Research Communications, Vol. 377, No. 1, 05.12.2008, p. 226-230.

Research output: Contribution to journalArticle

@article{e89b96c33a25403fa518bb2c00db93d7,
title = "An engineered split M.HhaI-zinc finger fusion lacks the intended methyltransferase specificity",
abstract = "The ability to site-specifically methylate DNA in vivo would have wide applicability to the study of basic biomedical problems as well as enable studies on the potential of site-specific DNA methylation as a therapeutic strategy for the treatment of diseases. Natural DNA methyltransferases lack the specificity required for these applications. Nomura and Barbas [W. Nomura, C.F. Barbas 3rd, In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase, J. Am. Chem. Soc. 129 (2007) 8676-8677] have reported that an engineered DNA methyltransferase comprised of fragments of M.HhaI methyltransferase and zinc finger proteins has very high specificity for the chosen target site. Our analysis of this engineered enzyme shows that the fusion protein methylates target and non-target sites with similar efficiency.",
keywords = "DNA methylation, Protein engineering, Zinc fingers",
author = "Meister, {Glenna E.} and Srinivasan Chandrasegaran and Marc Ostermeier",
year = "2008",
month = "12",
day = "5",
doi = "10.1016/j.bbrc.2008.09.099",
language = "English (US)",
volume = "377",
pages = "226--230",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - An engineered split M.HhaI-zinc finger fusion lacks the intended methyltransferase specificity

AU - Meister, Glenna E.

AU - Chandrasegaran, Srinivasan

AU - Ostermeier, Marc

PY - 2008/12/5

Y1 - 2008/12/5

N2 - The ability to site-specifically methylate DNA in vivo would have wide applicability to the study of basic biomedical problems as well as enable studies on the potential of site-specific DNA methylation as a therapeutic strategy for the treatment of diseases. Natural DNA methyltransferases lack the specificity required for these applications. Nomura and Barbas [W. Nomura, C.F. Barbas 3rd, In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase, J. Am. Chem. Soc. 129 (2007) 8676-8677] have reported that an engineered DNA methyltransferase comprised of fragments of M.HhaI methyltransferase and zinc finger proteins has very high specificity for the chosen target site. Our analysis of this engineered enzyme shows that the fusion protein methylates target and non-target sites with similar efficiency.

AB - The ability to site-specifically methylate DNA in vivo would have wide applicability to the study of basic biomedical problems as well as enable studies on the potential of site-specific DNA methylation as a therapeutic strategy for the treatment of diseases. Natural DNA methyltransferases lack the specificity required for these applications. Nomura and Barbas [W. Nomura, C.F. Barbas 3rd, In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase, J. Am. Chem. Soc. 129 (2007) 8676-8677] have reported that an engineered DNA methyltransferase comprised of fragments of M.HhaI methyltransferase and zinc finger proteins has very high specificity for the chosen target site. Our analysis of this engineered enzyme shows that the fusion protein methylates target and non-target sites with similar efficiency.

KW - DNA methylation

KW - Protein engineering

KW - Zinc fingers

UR - http://www.scopus.com/inward/record.url?scp=54449086454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54449086454&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.09.099

DO - 10.1016/j.bbrc.2008.09.099

M3 - Article

C2 - 18835252

AN - SCOPUS:54449086454

VL - 377

SP - 226

EP - 230

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -